Sandoz Private Limited — Lansoprazole Exporter Profile
Indian Pharmaceutical Exporter · #1 for Lansoprazole · $3.5M export value · DGFT Verified
Sandoz Private Limited is the #1 Indian exporter of Lansoprazole with $3.5M in export value and 69 verified shipments. Sandoz Private Limited holds a 1.2% market share in Lansoprazole exports across 2 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.
Sandoz Private Limited — Lansoprazole Export Profile: Buyers & Destinations
Where Does Sandoz Private Limited Export Lansoprazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $2.0M | 49 | 80.7% |
| SLOVENIA | $475.2K | 20 | 19.3% |
Sandoz Private Limited exports Lansoprazole to 2 countries. The largest destination is CANADA accounting for 80.7% of Sandoz Private Limited's Lansoprazole shipments. These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lansoprazole from Sandoz Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SANDOZ CANADA INC. | CANADA | $1.4M | 36 |
| SANDOZ CANADA INC | CANADA | $620.9K | 13 |
| LEK D.D | SLOVENIA | $375.2K | 18 |
| LEK D.D. | SLOVENIA | $50.0K | 1 |
| LEK D D | SLOVENIA | $50.0K | 1 |
Sandoz Private Limited supplies Lansoprazole to 5 buyers globally. The largest buyer is SANDOZ CANADA INC. (CANADA), followed by SANDOZ CANADA INC (CANADA) and LEK D.D (SLOVENIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lansoprazole Export Value and How Much Does Sandoz Private Limited Contribute?
India exported $71.7M worth of Lansoprazole through 4,867 shipments from 316 suppliers to 105 countries, serving 687 buyers globally. Sandoz Private Limited contributes $3.5M to this total, accounting for 1.2% of India's Lansoprazole exports. Sandoz Private Limited ships Lansoprazole to 2 countries through 5 buyers.
What Is the Average Shipment Value for Sandoz Private Limited's Lansoprazole Exports?
Sandoz Private Limited's average Lansoprazole shipment value is $50.0K per consignment, based on 69 shipments totaling $3.5M. The largest destination is CANADA (80.7% of Sandoz Private Limited's Lansoprazole exports).
How Does Sandoz Private Limited Compare to Other Indian Lansoprazole Exporters?
Sandoz Private Limited ranks #1 among 316 Indian Lansoprazole exporters with a 1.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($20.8M), CIPLA LIMITED ($11.3M), CAPLIN POINT LABORATORIES LIMITED ($6.4M). Sandoz Private Limited processed 69 shipments to 2 destination countries.
What Lansoprazole Formulations Does Sandoz Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LANSOPRAZOLE HGC 30MG IN91 SH MS MATERIAL NO. - 42021949 | $482.2K | 12 |
| LANSOPRAZOLE HGC 30MG IN91 SH MS MATERIA | $400.0K | 8 |
| Material No. - 42021949, LANSOPRAZOLE HG | $182.7K | 4 |
| MATERIAL NO. 42021949 LANSOPRAZOLEHGC 30MG IN91 SH MS | $130.4K | 3 |
| LANSOPRAZOLE HGC 30MG IN91 SH MS MATERIAL NO. - 42021949PCS | $106.8K | 3 |
| Material No.-42021949, LANSOPRAZOLE HGC30MG IN91 SH MS , BATCH NO.PK7988, PK7719 , PK7989 MFG DATE:17.03.2025, 08.03.20 | $100.0K | 2 |
| Material No. - 42021949 LANSOPRAZOLE HGC | $84.9K | 2 |
| Material No. - 42025109, LANSOPRAZOLE GR | $50.0K | 1 |
| Material No - 42021949 LANSOPRAZOLE HGC | $50.0K | 1 |
| Material No 42025109 LANSOPRAZOLE GRC30MG IN91 SH EU BATCH NO MS5666 MS664 MFG DATE 10 01 2023 DATA LOGGER AS PER | $50.0K | 1 |
Sandoz Private Limited exports 31 distinct Lansoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LANSOPRAZOLE HGC 30MG IN91 SH MS MATERIAL NO. - 42021949 with 12 shipments worth $482.2K.
Regulatory Requirements: Exporting Lansoprazole to Key Markets
What Sandoz Private Limited must comply with to export Lansoprazole to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sandoz Private Limited Compare to Nearest Lansoprazole Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | HETERO LABS LIMITED | $4.6M | 154 | 10 | $30.1K |
| 10 | MICRO LABS LIMITED | $3.7M | 87 | 16 | $42.7K |
| 1 | SANDOZ PRIVATE LIMITED ★ | $3.5M | 69 | 2 | $50.0K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $2.1M | 43 | 3 | $50.0K |
| 12 | ALKEM LABORATORIES LIMITED | $2.0M | 40 | 2 | $50.0K |
Sandoz Private Limited ranks #1 among 316 Indian Lansoprazole exporters. Average shipment value of $50.0K compared to the market average of $227.0K. The closest competitors by value are HETERO LABS LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Lansoprazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 729 | 15.0% |
| DELHI AIR CARGO ACC (INDEL4) | 577 | 11.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 416 | 8.5% |
| DELHI AIR | 364 | 7.5% |
| NHAVA SHEVA SEA (INNSA1) | 264 | 5.4% |
| JNPT/ NHAVA SHEVA SEA | 209 | 4.3% |
| Bombay Air | 140 | 2.9% |
| JNPT | 106 | 2.2% |
Geopolitical & Trade Policy Impact on Sandoz Private Limited's Lansoprazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.
Sandoz Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.
The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.
About Sandoz Private Limited
Sandoz Private Limited exports 25 products worth $159.4M. Beyond Lansoprazole, top products include Tacrolimus, Apixaban, Citalopram, Escitalopram, Gabapentin. View the complete Sandoz Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lansoprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lansoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 69 individual customs records matching Sandoz Private Limited exporting Lansoprazole, covering 31 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 105+ countries, 687+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lansoprazole Export Data from Sandoz Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sandoz Private Limited's Lansoprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sandoz Private Limited
Full Company Profile →
25 products · $159.4M total trade · 15 categories
Lansoprazole Stats
Company Overview
Top Products by Sandoz Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sandoz Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lansoprazole. For current shipment-level data, contact TransData Nexus.